A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04914429 · COMPLETED
Trial details
- NCT number
- NCT04914429
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-25
- Primary completion
- 2023-09-26
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.